Performance Evaluation of DIY Digital Visual Acuity Test

NCT ID: NCT07331870

Last Updated: 2026-01-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-01

Study Completion Date

2025-11-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to verify the accuracy of a new Digital Visual Acuity test. The test results obtained with the support of the device will be compared to the current standard of care related to visual acuity testing.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigational device is a software-based application for computers and tablets that enables individuals without professional training to self-assess their near and distance visual acuity. It is a low-risk device and represents an evolution of an already marketed product. The device is intended to support ongoing monitoring for patients with conditions that may affect visual acuity, helping track changes over time. It is not designed to replace a comprehensive eye examination performed by a qualified eye-care professional. For this study, the advanced version of the application will be used.

The study population will include adults with normal, subnormal, and low vision to ensure validation of the test across the full range of visual acuity levels. Participants will include patients attending the Eye Department for treatment of various ocular conditions (low-vision group), as well as patients' spouses and department staff (subnormal and normal vision groups). All participants must be able to make independent judgments. Before participation, each individual will receive information about the study procedures, including the nature of the intervention and their right to withdraw at any time.

The device does not require specialized training. Users will receive a brief initial orientation on how to operate the application. For the home self-test, users will complete the assessment independently and without assistance to evaluate the device's usability and support autonomous testing.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Visual Acuity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

No making applied

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Comparaison to standard of Care

The measurements performed with the investigational device are compared to the standard of care (ETDRS and Radner test)

Group Type EXPERIMENTAL

Comparaison of the investigation device measurement with standard of Care

Intervention Type DEVICE

The patient Visual acuity is measured with the investigational device, the ETDRS method, the radner test and the results are compared.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Comparaison of the investigation device measurement with standard of Care

The patient Visual acuity is measured with the investigational device, the ETDRS method, the radner test and the results are compared.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age and older.
* Subjects must be able to understand and perform the test.
* Subject must have corrected vison (i.e. wearing glasses)

Exclusion Criteria

* Subjects not able to understand the implications of participating in a scientific study.
* Subjects not legally independent.
* Subjects not able to perform the test.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Veranex Switzerland SA

INDUSTRY

Sponsor Role collaborator

Ojenforeningen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lisbeth Sandfeld, PhD MD

Role: PRINCIPAL_INVESTIGATOR

Zealand University Hospital, Roskilde, Denmark

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Eye Dept., Zealand University Hospital

Roskilde, Denmark, Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Ojenforeningen

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Digital Wavefront Sensing
NCT04597255 UNKNOWN NA
Functional Assessments in Vision Impairment
NCT06908161 NOT_YET_RECRUITING
Retinal Investigation Using Optos OCT Device
NCT06846151 NOT_YET_RECRUITING NA
High Resolution Imaging OCT Study
NCT07338461 NOT_YET_RECRUITING NA